Ramelteon Impurity
|
雷美替胺雜質(zhì)56
|
1242672-46-3
|
Ramelteon Impurity
|
雷美替胺雜質(zhì)58
|
221530-42-3
|
Ramelteon Impurity
|
雷美替胺雜質(zhì)10
|
896736-22-4
|
Ramelteon Impurity
|
RaMelteon IMpurity 3
|
880152-62-5
|
Ethyl 2-chloroacetoacetate
|
2-氯乙酰乙酸乙酯
|
609-15-4
|
Nicorandil Impurity
|
6-Hydroxy Nicorandil
|
113743-17-2
|
Ramelteon Impurity
|
WBYZCPYZHMZPHD-UHFFFAOYSA-N
|
1221160-70-8
|
Ramelteon Impurity
|
4-bromo-1,2,6,7-tetrahydro-8H-Indeno[5,4-b]furan-8-one
|
196597-69-0
|
Ramelteon Impurity
|
4,5-二溴-1,2,6,7-四氫-8H-茚并[5,4-B]呋喃-8-酮
|
196597-77-0
|
Ramelteon Impurity
|
雷美替胺雜質(zhì)H
|
196597-76-9
|
Ramelteon Impurity
|
S-布洛芬
|
51146-56-6
|
Ramelteon Impurity
|
N- [2-(1,6,7,8-四氫-2H-茚并[5,4-b]呋喃-8-基)乙基]- 丙酰胺
|
196597-17-8
|
Ponatinib Impurity
|
咪唑并[1,2-b]噠嗪
|
766-55-2
|
Ponatinib Impurity
|
3-硝基-2-三氟甲基甲苯
|
112641-21-1
|
Pazopanib Impurity
|
2-氯-4-羥基嘧啶
|
55873-09-1
|
Pazopanib Impurity
|
Pazopanib Related Compound 3
|
1252927-44-8
|
Pazopanib Impurity
|
Pazopanib Related Compound 2
|
1226500-02-2
|
Gadobutrol Monohydrate
|
釓布醇 一水合物
|
198637-52-4
|
Gadobutrol
|
釓布醇
|
138071-82-6
|
Apremilast ImpurityND
|
635705-72-5
|
Acalabrutinib Impurity
|
阿可替尼代謝物27
|
2230757-47-6
|
Acalabrutinib
|
阿卡替尼
|
1420477-60-6
|
L-Citrulline
|
L-瓜氨酸
|
372-75-8
|
Prucalopride Impurity
|
Prucalopride Impurity 1
|
1900715-96-9
|
Brexpiprazole Impurity
|
Brexpiprazole Impurity 76
|
433303-94-7
|
Noradrenaline Impurity
|
去甲腎上腺素磺酸
|
24159-36-2
|
1,4-Di-tert-butyl piperazine-1,4-dicarboxylate
|
1,4-雙(叔丁氧羰基)哌嗪
|
76535-75-6
|
Apixaban Impurity
|
阿哌沙班雜質(zhì)6
|
1074365-84-6
|
Ursodiol Impurity
|
熊果膽酸
|
2955-27-3
|
Ivabradine related compound 11
|
(1S)-4,5-二甲氧基-1-(甲基氨基甲基)-苯并環(huán)丁烷
|
866783-12-2
|
Monocaprylin
|
單辛酸甘油酯
|
26402-26-6
|
Nicorandil Impurity
|
尼可地爾氮氧化物
|
107833-98-7
|
Folic Acid Impurity
|
6-hydroxymethylpterin
|
712-29-8
|
5-Bromobenzo[b]thiophene
|
5-溴苯并[b]噻吩
|
4923-87-9
|
Ramelteon Impurity
|
雷美替胺雜質(zhì)B
|
196597-16-7
|
Ramelteon Impurity
|
1,2,6,7-四氫-8H-茚并[5,4-b]呋喃-8-酮
|
196597-78-1
|
Tosufloxacin tosylate hydrate
|
對(duì)甲苯磺酸妥舒沙星水合物
|
1400591-39-0
|
4-Methylbenzophenone
|
4-甲基二苯甲酮
|
134-84-9
|
Ciclesonide Impurity
|
[11BETA,16ALPHA(S)]-16,17-[(環(huán)己基亞甲基)雙(氧基)]-11-羥基-21-(2-甲基-1-氧代丙氧基)-孕-1,4-二烯-3,20-二酮
|
141845-81-0
|
Dolutegravir Impurity
|
杜魯特韋雜質(zhì)56
|
2384108-28-3
|
Dolutegravir Impurity
|
多替拉韋雜質(zhì)03
|
2730133-58-9
|
Peramivir Impurity
|
(1R,4R)-4-BOC-氨基-2-環(huán)戊烯-1-羧酸甲脂
|
168958-19-8
|
Peramivir Impurity
|
帕拉米韋雜質(zhì)
|
383910-24-5
|
Argatroban Impurity
|
N-Boc-N'-硝基-L-精氨酸
|
2188-18-3
|
2,4,6-Collidine
|
2,4,6-三甲基吡啶
|
108-75-8
|
Cefditoren Impurity
|
頭孢他美酯
|
65243-33-6
|
Argatroban Impurity
|
Argatroban Impurity 33
|
450368-56-6
|
Argatroban Impurity
|
(2R,4R)-4-甲基-2-哌啶甲酸
|
74892-81-2
|
Argatroban Impurity
|
阿加曲班雜質(zhì)D
|
79672-38-1
|
Citicoline sodium Impurity
|
胞苷5'-單磷酸甲酯
|
52448-10-9
|
Tenofovir alafenamide Impurity
|
Phosphorous acid, diphenyl ester
|
102-10-3
|
Moxidectin Impurity
|
Milbemycin B, 5-O-demethyl-28-deoxy-6,28-epoxy-23-(methoxyimino)-25-(1-methyl-1-butenyl)-, [6R,23E,25S(E)]- (9CI)
|
114041-23-5
|
Argatroban
|
阿加曲班
|
74863-84-6
|
1,3,5-Trimethoxybenzene
|
1,3,5-三甲氧基苯
|
621-23-8
|
Imrecoxib
|
艾瑞昔布
|
395683-14-4
|
Paliperidone Impurity
|
帕潘立酮去氟雜質(zhì)
|
1380413-60-4
|
Meloxicam Impurity
|
美洛昔康雜質(zhì)2
|
1865298-74-3
|
Isotretinoin Impurity
|
4-甲氧基維甲酸
|
81121-20-2
|
Isotretinoin Impurity
|
4-KETO全反式維甲酸
|
38030-57-8
|
Ponatinib
|
帕納替尼
|
943319-70-8
|
Nicorandil Impurity
|
尼可地爾雜質(zhì)8
|
83440-03-3
|
Ponatinib Impurity
|
泊那替尼雜質(zhì)10
|
10388-23-5
|
Ponatinib Impurity
|
3-(2-咪唑[1,2-B]吡嗪-3-基乙炔基)-4-甲基苯甲酸
|
1300690-48-5
|
Ponatinib Impurity
|
帕納替尼雜質(zhì)2
|
2097674-16-1
|
Ponatinib Impurity
|
3-三氟甲基-4-[(4-甲基哌嗪-1-基)甲基]苯胺
|
694499-26-8
|
Ponatinib Impurity
|
3-乙炔基-4-甲基苯甲酸甲酯
|
1255099-13-8
|
Ponatinib Impurity
|
943319-87-7
|
943319-87-7
|
Vinorelbine Impurity
|
硫酸長(zhǎng)春新堿
|
2068-78-2
|
4-Bromobenzo[b]thiophene
|
4-溴苯并[B]噻吩
|
5118-13-8
|
Brexpiprazole Impurity
|
1-溴-4-氯丁烷
|
6940-78-9
|
Azelnidipine Impurity
|
2-(3-硝基亞芐基)乙酰乙酸異丙酯
|
39562-25-9
|
Azelnidipine Impurity
|
阿折地平雜質(zhì)
|
918659-10-6
|
Azelnidipine Impurity(Acetate)
|
3-氨基-3-亞氨基丙酸 1-(二苯甲基)-3-氮雜環(huán)丁酯乙酸鹽
|
170749-59-4
|
Azelnidipine Impurity
|
N-二苯甲基氮雜環(huán)丁烷-3-醇
|
18621-17-5
|
Azelnidipine
|
阿折地平
|
123524-52-7
|
Edoxaban Tosylate
|
伊多塞班對(duì)甲苯磺酸鹽
|
480449-71-6
|
Pemetrexed Impurity
|
4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoic Acid Methyl Ester
|
1320346-43-7
|
Nebivolol Impurity
|
奈比洛爾雜質(zhì)
|
197706-51-7
|
Nebivolol Impurity
|
奈比洛爾雜質(zhì)
|
197706-50-6
|
Methylene Blue Impurity
|
|
126656-05-1
|
Methylene Blue Impurity(Chloride salts)
|
|
1242769-80-7
|
Azilsartan Impurity
|
乙基異丙基亞硝胺
|
16339-04-1
|
Methylene Blue Impurity
|
|
5768-69-4
|
Sildenafil Impurity
|
N-去甲基西地那非
|
139755-82-1
|
Vibegron Impurity(Hydrochloride)
|
(1R,2R)-2-AMINO-6-(4-NITROPHENYL)-1-PHENYLHEX-5-YN-1-OLHYDROCHLORIDE
|
1628836-08-7
|
Granisetron Impurity
|
內(nèi)向-3-氨基-9-甲基-9-氮雜雙環(huán)[3,3,1]壬烷
|
76272-56-5
|
abozantinib Impurity
|
D-(+)-蘋(píng)果酸
|
636-61-3
|
Antioxidant 3114
|
抗氧劑 3114
|
27676-62-6
|
Vibegron Impurity
|
tert-butyl(4R,5R)-4-(hydroxymethyl)-2,2-dimethyl-5-phenyloxazolidine-3-carboxylate
|
1009092-91-4
|
Vibegron Impurity
|
維貝格龍中間體
|
136620-75-2
|
Vibegron
|
維貝格隆
|
1190389-15-1
|
Diltiazem Impurity
|
N-去甲鹽酸地爾硫卓
|
86408-45-9
|
Sildenafil Impurity
|
西地那非雜質(zhì)A
|
1391053-95-4
|
Glycine Impurity
|
肌氨酸
|
107-97-1
|
Vibegron Impurity
|
維貝格隆(維貝隆)雜質(zhì)1
|
439612-08-5
|
Vibegron Impurity
|
維貝格隆(維貝隆)雜質(zhì)2
|
136620-82-1
|
Nebivolol Impurity(RR,SS)
|
2H-1-Benzopyran-2-methanol, α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, (αR,α'S,2R,2'S)-
|
1360598-84-0
|
Methylene Blue Impurity
|
|
15967-15-4
|
Ponatinib Impurity
|
泊那替尼雜質(zhì)1
|
1952344-01-2
|
Isotretinoin Impurity
|
異維甲酸雜質(zhì)13
|
68070-34-8
|